New Zealand markets closed
  • NZX 50

    +221.23 (+1.69%)

    -0.0023 (-0.32%)

    -0.0019 (-0.33%)

    -28.20 (-0.40%)
  • ASX 200

    -23.30 (-0.34%)
  • OIL

    -0.70 (-1.32%)
  • GOLD

    -3.10 (-0.17%)

    0.00 (0.00%)
  • FTSE

    -24.97 (-0.37%)
  • Dow Jones

    -12.39 (-0.04%)
  • DAX

    -14.73 (-0.11%)
  • Hang Seng

    -398.40 (-1.33%)
  • NIKKEI 225

    -77.18 (-0.27%)

    -0.1900 (-0.25%)

The Zacks Analyst Blog Highlights: Whiting Petroleum, Extraction OG, Chesapeake Energy and California Resources

Zacks Equity Research
·6-min read

For Immediate Release

Chicago, IL – June 30, 2020 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Whiting Petroleum Corp. WLL, Extraction OG XOGAQ, Chesapeake Energy Corp. CHK and California Resources Corp. CRC.

Here are highlights from Monday’s Analyst Blog:

U.S. Shale Industry to Lose $300 Billion: Stocks to Watch

The fate of the U.S. shale industry seems to be doomed, at least in the near term, with industry players projected to write down the value of their assets by a whopping $300 billion, per a recent estimate by Deloitte. The firm expects the industry to witness notable resource impairments and asset write-offs during the second quarter of 2020, which, in the worst case scenario, might lead to a wave of bankruptcies.

Such estimated impairment charges cloud the industry's growth prospects. On top of that, with debt level staying the same, it’s the industry’s leverage ratio, which is going to shoot up in the near future. The Deloitte report has found 30% of shale operators being technically insolvent with oil prices at $35, while 20% are stressed financially.

Reasons Behind the Industry’s Fall

Thanks to the inelastic demand for petroleum, backed by rapidly increasing transportation, construction, power generation and travelling activities, the U.S. shale industry has been booming over the past few years. Nevertheless, this boom seems to have been only in terms of oil production growth and not in terms of cash generation. Notably, tight oil production more than doubled over the past five to six years. However, the industry experienced over $450 billion of invested capital impairment and lost $300 billion in net cash flow over the past 15 years.

One of the primary headwinds affecting this industry’s players is oil price war among producers. Even as the industry was coping with this headwind, the novel coronavirus outbreak hit hard and changed the entire dynamics. Starting from March 2020, oil demand started to sink rapidly as stringent lockdowns were imposed and regular economic activities were stalled.

Consequently, oil prices tumbled significantly and reached their worst, causing West Texas Intermediate (WTI) crude to plunge into negative territory for the first time, owing to repressed demand and lack of oil storage. Adding to the woes of the industry, along with the price fall came significant production cuts. According to data from Genscape, oil price crash led to at least 1.5 million bpd of production shut-ins between the beginning of April and late May.

Stocks to Watch

With the U.S. shale industry having witnessed over 190 bankruptcies since 2010, we focus on the following oil stocks that have either reportedly filed for bankruptcy or are expected to do so going forward. Since their 2020 sales and earnings estimates indicated dismal performance, prudent investors need to exercise caution while keeping them in their portfolio.

Whiting Petroleum Corp.: Denver, CO-based Whiting Petroleum Corporation is an independent energy company engaged in the exploration, development and production of crude oil and natural gas properties in the United States. It filed for bankruptcy on Apr 1, making it the first U.S. shale producer to go for insolvency. The Zacks Consensus Estimate for its 2020 sales indicates decline of 43.9%, while that for earnings indicates a plunge of 386.1%.

Extraction OG: Denver-based Extraction Oil& Gas is focused on the acquisition, development and production of oil, natural gas and natural gas liquids reserves. In mid-June, it filed for bankruptcy. The Zacks Consensus Estimate for 2020 sales implies decline of 29.4%, while that for earnings indicates a drop of 93.5%.

Chesapeake Energy Corp.: Oklahoma City, OK –based Chesapeake Energy is primarily an oil, natural gas and NGL exploration and production company. Per major media resources, this shale pioneer is preparing for a potential bankruptcy filing, after reporting a loss of $8.3 billion in the first quarter and skipping interest payments of $13.5 million, according to SEC filings. The consensus estimate for 2020 sales suggests decline of 18.4%, while that for earnings indicates decline of 43.8%.

California Resources Corp.: Los Angeles-based California Resources is engaged in exploration and production of oil and gas. The company is talking with lenders for a financing package of up to $600 million to carry its operations through a planned bankruptcy proceeding, after it failed to make a $30 million interest payment, the Wall Street Journal reported. The consensus estimate for its 2020 sales indicates decline of 36.1%, while that for earnings indicates a plunge of 885.7%.

Recovery in sight?

U.S. oil price has been ticking up a little bit over the past few days and so has been oil production. Still considering the fact that COVID-19 is here to stay for a while, along with its resultant economic turmoil, a stark rebound in the U.S. shale industry will be hard to achieve any time soon. Analysts at Enverus and IHS Markit told Bloomberg that production will likely take until at least 2023 to return to the pre-oil price crash levels.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339                                                                            

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
California Resources Corporation (CRC) : Free Stock Analysis Report
Whiting Petroleum Corporation (WLL) : Free Stock Analysis Report
EXTRACTION OG (XOGAQ) : Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research